Oral Intake Of Eranda Taila In The Management Of Primary Dysmenorrhea.
Phase 2
- Conditions
- Health Condition 1: E308- Other disorders of puberty
- Registration Number
- CTRI/2023/09/057578
- Lead Sponsor
- Dr Sneha Sureshrao Hake
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Painful Menstruation For Atleast 3 Consecutive Cycle
2 Patient With Regular Menstrual Cycle 21 to 35 days
Exclusion Criteria
1 Patient Having Secondary Dysmenorrhea Like Fibroid Adenomyosis Endometriosis
2 Severe Anemic Hb less than 7 gm percent
3 Abdominal Pain Associated With Excessive Bleeding Per Vagina
4 Irregular Menstrual Cycle
5 Any Other Abdominal Pain Like Gastritis Colitis
6 Polycystic Ovarian Disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method